Related Experiment Video

Updated: Aug 27, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Pneumococcal endocarditis in infants and children

Margaret Choi1, Timothy Lloyd Mailman

  • 1Department of Pediatrics, University of British Columbia, British Columbia Children's Hospital, Vancouver, BC, Canada.

The Pediatric Infectious Disease Journal
|February 12, 2004
PubMed

Insights

Pediatric pneumococcal endocarditis (PPE) is a rare, aggressive infection. Early surgical intervention alongside medical treatment improves survival rates for this serious condition.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Cardiology

Background:

  • Pediatric pneumococcal endocarditis (PPE) is a rare but serious infection.
  • Increasing antibiotic resistance may contribute to its rising incidence.
  • Understanding PPE's unique characteristics in children is crucial for timely diagnosis and management.

Observation:

  • A review identified 32 cases of PPE since 1900, with a notable increase since 1990.
  • Pediatric cases frequently involve the mitral valve and rarely present with Osler's triad, differing from adult presentations.
  • Congenital heart disease was the primary identified risk factor in pediatric patients.

Findings:

  • Medical therapy alone yielded high mortality rates in pediatric patients.
  • Combined medical and surgical interventions significantly improved survival outcomes.
  • PPE presents as an aggressive infection with a high mortality rate, distinct from subacute bacterial endocarditis.

Implications:

  • Early surgical intervention is recommended to improve survival in pediatric pneumococcal endocarditis.
  • This highlights the need for heightened awareness and prompt management strategies for PPE in pediatric populations.
  • Further research into optimal treatment protocols for PPE is warranted, especially in the context of evolving antibiotic resistance patterns.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: